Power Law company profile

Imago BioSciences

Biotech & Life Sciences · San Carlos, United States · Founded 2012 · IPO 2021 Unicorn

We are a company dedicated to translating state-of-the art science into novel medicines for the treatment of diseases

Valuation

$1.04B

Market cap · 2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

16 investors on Imago BioSciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

Clarus Ventures

Amgen Ventures

Frazier Healthcare Partners

Series B+ 13 investors entered at this stage

Irving Investors

BlackRock

Citadel

Farallon Capital Management

Blackstone

MRL Ventures

Xeraya Capital

Omega Funds

Kingdon Capital

Highlight Capital

Greenspring Associates

T. Rowe Price

Pharmaron Holding

Global footprint

Where Imago BioSciences has talent and traffic

Workforce by country

🇺🇸 United States · San Carlos HQ

Book a demo for the full country breakdown

Patent intelligence

$32M patent portfolio · 14 active families

Estimated portfolio value

$32M

3.1% of market cap · 16.4× smaller than top peer ChemoCentryx ($524M)

14 active patent families

Where Imago BioSciences innovates DiseaseMolecular biologyCancer researchKDM1AGlobin gene expression

Where Imago BioSciences concentrates vs peers

Each axis is a top-10 topic across Imago BioSciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Imago BioSciences

An AI-synthesized read of the highest-engagement posts about Imago BioSciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Imago BioSciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles